InsidersTradesSigma
대웅제약: directors' dealings · South Korea · DART (FSS)
DART:company-f4f526KR·DART (FSS)Mcap 1982.5Bn€
Explore the full directors' dealings record of 대웅제약, a publicly traded company based in South Korea. Shares trade on KR KR, under the authority of DART (FSS). Market capitalisation: €1,982.5bn. The latest transaction was filed on 27 March 2026 — Sale. Among the most active insiders: 대웅. All data is free.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
133100.00 €
Income statement
Revenue1570.89 Bn€
Gross profit822.53 Bn€52% margin
Net income195.86 Bn€12.5% margin
Balance sheet & cash
Market cap1982.53 Bn€
Total debt829.39 Bn€
Free Cash Flow−92.16 Bn€
Last declaration on 27 March 2026